Key facts
- Sycai Medical’s last known valuation is $3.1M (Feb 2022).
- It has raised $4.0M; the latest was Later Stage VC ($3.1M) in Dec 2024.
- Notable investors include Draper B1, Athos Capital, Lumo Labs, ACCIÓ, BStartup10 — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Sycai Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Sycai Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sycai Medical
Developer of medical imaging technology designed to improve healthcare through artificial vision and big data. The company helps medical professionals diagnose abdominal injuries and predict their evolution to increase early-stage cancer detection and improve the quality of life of patients with chronic diseases, enabling radiologists to fight against cancer through AI and medical imaging.
- Sector
- Healthcare
- HQ
- Barcelona, Spain
- Founded
- 2020
- Employees
- 22
- Website
- sycaimedical.com/
- Ownership
- Privately Held (backing)
Sycai Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sycai Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sycai Medical in its N-PORT filings yet. We sweep new filings monthly.